Differential Expression of SDF-1 Isoforms in Bladder Cancer

    Authors

    M. Gosalbez; M. C. Hupe; S. D. Lokeshwar; T. J. Yates; J. Shields; M. K. Veerapen; A. S. Merseburger; C. J. Rosser; M. S. Soloway;V. B. Lokeshwar

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    J. Urol.

    Keywords

    urinary bladder neoplasms; chemokine CXCL12; tumor markers, biological; prognosis; neoplasm recurrence, local; CELL CARCINOMA; BREAST-CANCER; CHEMOKINE; RECEPTOR; CXCL12; CXCR7; PROGRESSION; SURVIVAL; DISEASE; AXIS; Urology & Nephrology

    Abstract

    Purpose: SDF-1 is a ligand of the chemokine receptors CXCR4 and 7. The 6 known SDF-1 isoforms are generated by alternative mRNA splicing. While SDF-1 expression has been detected in various malignancies, only few groups have reported differential expression of SDF-1 isoforms and its clinical significance. We evaluated the expression of 3 SDF-1 isoforms (alpha, beta and gamma) in bladder cancer. Materials and Methods: Using quantitative polymerase chain reaction we measured SDF-1 alpha, beta and gamma mRNA levels in 25 normal and 44 bladder cancer tissues, and in 210 urine specimens (28 normal, 74 benign, 57 bladder cancer, 35 bladder cancer history, 8 other cancer history and 8 other cancer) from consecutive patients. Levels were correlated with clinical outcome. Results: Of the SDF-1 isoforms only SDF-1 beta mRNA was significantly over expressed 2.5-fold to sixfold in bladder cancer compared to normal bladder tissues. SDF-1 alpha was expressed in bladder tissues but SDF-1 gamma was undetectable. On multivariate analysis SDF-1 beta was an independent predictor of metastasis and disease specific mortality (p = 0.017 and 0.043, respectively). In exfoliated urothelial cells only SDF-1 beta mRNA levels were differentially expressed with 91.2% sensitivity and 73.8% specificity for detecting bladder cancer. In patients with a bladder cancer history increased SDF-1 beta levels indicated a 4.3-fold increased risk of recurrence within 6 months (p = 0.0001). Conclusions: SDF-1 isoforms are differentially expressed in bladder tissues and exfoliated urothelial cells. SDF-1 beta mRNA levels in bladder cancer tissues predict a poor prognosis. Furthermore, SDF-1 beta mRNA levels in exfoliated cells detect bladder cancer with high sensitivity and they are a potential predictor of future recurrence.

    Journal Title

    Journal of Urology

    Volume

    191

    Issue/Number

    6

    Publication Date

    1-1-2014

    Document Type

    Article

    Language

    English

    First Page

    1899

    Last Page

    1905

    WOS Identifier

    WOS:000336531100102

    ISSN

    0022-5347

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.